医 疗的本质，是对生命的探索。而当AI与医疗相结合，这场探索将变得更快、更精准。 由于行业的严肃性和复杂性，长久以来，医疗健康始终被视为新兴技术应用中最难啃下的硬骨头。但现在，AI的崛起正在彻底改写这一局面。由于"天花 板"足够高，医疗正在成为AI最有前景的核心赛道之一。 从AI制药、医疗影像诊断、临床专病智能辅助决策，过去几年，"AI+医疗"的技术迭代层出不穷。国内医疗机构纷纷接入大模型，科技大厂也在积极布局 AI医疗赛道，国家层面"人工智能+医疗卫生"政策的相继出台也在推动医疗生态的智能转型。 AI正加速重构医疗行业的运转方式。而这场变革的最佳切入点，或许是解放医生的时间。 2021年，清华大学社科学院的一份医师调研报告显示，医师平均每天出诊时间约为7.77小时、科研时间约为1.47小时。与此同时，近七成医生认为"科 研、发论文压力大"。在工作、科研的双重压力之下，医生作为"临床打工人"的职业倦怠常年处于较高水平。 如何将医生从繁重的事务中解放出来，成了医疗体系效率提升的关键命题。 科研难题往往不在于缺乏想法，而在于缺乏时间和工具。此次发布会上重磅推出的AI科研工具"小罗智多星"，正是基于这一洞察而诞生。 ...

Core Insights - The integration of AI in the medical and pharmaceutical sectors is becoming increasingly prominent, with numerous innovative products showcased at the China International Import Expo, highlighting AI's role in drug development, clinical efficiency, and decision-making [1][2][6]. Group 1: AI Empowerment in Medical Research and Drug Development - The Chinese government has implemented policies to promote AI in the pharmaceutical industry, emphasizing the use of new information technologies in drug research [2]. - Major multinational companies like Roche, AstraZeneca, Johnson & Johnson, and Siemens Healthineers are collaborating with AI firms to advance various projects [2][3]. - Roche's AI-driven solutions, such as the "MDT Intelligent Body" and "Little Roche Smart Star," aim to enhance clinical practice efficiency and support the entire research process, having already assisted over 4,000 doctors in completing more than 600 research projects [3]. Group 2: AI in Medical Devices and Diagnostics - The introduction of AI-powered medical devices is transforming traditional healthcare practices, with companies like Medtronic showcasing their AiBLE smart ecosystem that integrates surgical robots and imaging systems [6]. - Siemens Healthineers presented its AI-driven innovations, including a prostate cancer diagnostic software that enhances detection accuracy and reduces misdiagnosis risks [7]. - Boston Scientific debuted several AI-enabled cardiac health innovations, including the FDA-approved HeartLogic heart failure monitoring system, which can predict heart failure risks [7]. Group 3: Brain-Computer Interface Technology - Brain-computer interface (BCI) technology is emerging as a revolutionary treatment paradigm, enabling patients with severe disabilities to control devices through thought [11][12]. - Siemens Healthineers introduced a comprehensive BCI solution that covers preoperative planning, intraoperative navigation, and postoperative evaluation, facilitating the clinical application of BCI technology [12]. - Medtronic showcased a rechargeable, perceptive closed-loop brain stimulator that offers personalized treatment for conditions like Parkinson's disease, enhancing patient care [12].